Company / CapEx per Share
Ventyx Biosciences, Inc. CapEx per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.02
FY2021-FY2024
Trend
-59.9%
vs FY2023
Sector context
#149 of 191
Health Care
What the data says
Ventyx Biosciences, Inc.'s capex per share of $0.00 is lower than 78% of companies in the Health Care sector (FY2024). Declined from $0.01 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of -44.4%.
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -44.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 191This company $0.00 Sector average $4.05
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 59.9% year-over-year.
- Ranks #149 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -59.9% |
| FY2023 | $0.01 | +67.5% |
| FY2022 | $0.01 | -74.3% |
| FY2021 | $0.02 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026